SLPI controls neutrophil migration abilities and impacts neutrophil skin infiltration in experimental psoriasis
Authors:
- Patrycja KwiecinskaPKPatrycja Kwiecinska
- Michal SantockiMSMichal Santocki
- Joanna Skrzeczynska-MoncznikJSJoanna Skrzeczynska-Moncznik
- Katarzyna PiwowarczykKPKatarzyna Piwowarczyk
- Pawel MajewskiPMPawel Majewski
- Beata GrygierBGBeata Grygier
- Monika Majchrzak-GoreckaMMMonika Majchrzak-Gorecka
- Jaroslaw CzyzJaroslaw Czyz
- Elzbieta KolaczkowskaEKElzbieta Kolaczkowska
- Joanna CichyJCJoanna Cichy
Open Access
- 10 February 2025
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 82 (1) , 1-14
Abstract
Skin infiltration by neutrophils is a hallmark of the chronic inflammatory skin disease psoriasis, yet the mechanisms underlying neutrophil recruitment and positioning in chronically inflamed skin remain poorly understood. In this study, we demonstrate the significant impact of a total genetic deficiency of secretory leukocyte protease inhibitor (SLPI) on neutrophil migration in mouse skin. Without SLPI, neutrophils displayed an unconventional migratory pattern, characterized by altered interactions with vessel walls and reduced efficiency in extravasating from blood vessels into skin tissue during the early stages of experimental psoriasis. This was associated with changes in tissue motility, positioning neutrophils farther from the skin entry vessels and closer to the skin surface. Neutrophil diapedesis was partially dependent on SLPI within the neutrophils themselves. The impact of SLPI on neutrophil movement was further supported by the increased migration of human neutrophils in the presence of neutrophil-penetrant recombinant SLPI. Additionally, our data suggest that neutrophils with varying capacities for vessel wall interaction are released from the bone marrow into circulation in an SLPI-dependent manner. These findings establish a role for SLPI in regulating the spatiotemporal infiltration of neutrophils into the skin in psoriasis, highlighting its relevance to psoriasis pathophysiology.Keywords
Funding Information
- Narodowe Centrum Nauki (UMO-2022/45/B/NZ6/03581)
This publication has 29 references indexed in Scilit:
- Neutrophil-Derived MicroRNA-1290 Promotes Keratinocyte Proliferation in PsoriasisJournal of Investigative Dermatology, 2023
- Neutrophils Enhance Cutaneous Vascular Dilation and Permeability to Aggravate Psoriasis by Releasing Matrix Metallopeptidase 9Journal of Investigative Dermatology, 2021
- Differences in Staining for Neutrophil Elastase and its Controlling Inhibitor SLPI Reveal Heterogeneity among Neutrophils in PsoriasisJournal of Investigative Dermatology, 2020
- Neutrophil Extracellular Traps Induce Human Th17 Cells: Effect of Psoriasis-Associated TRAF3IP2 GenotypeJournal of Investigative Dermatology, 2019
- Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family CytokinesCell Reports, 2016
- Leukotriene B4-Neutrophil Elastase Axis Drives Neutrophil Reverse Transendothelial Cell Migration In VivoImmunity, 2015
- A Myeloperoxidase-Containing Complex Regulates Neutrophil Elastase Release and Actin Dynamics during NETosisCell Reports, 2014
- Neutrophil serine proteases fine-tune the inflammatory responseThe International Journal of Biochemistry & Cell Biology, 2008
- Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healingNature Medicine, 2000
- Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophilsJournal of Leukocyte Biology, 1997